{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T13:18:41Z","timestamp":1778591921245,"version":"3.51.4"},"reference-count":33,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,29]],"date-time":"2024-07-29T00:00:00Z","timestamp":1722211200000},"content-version":"vor","delay-in-days":210,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["221690\/Z\/20\/Z"],"award-info":[{"award-number":["221690\/Z\/20\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021672","name":"NIHR Leicester Clinical Research Facility","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021672","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["RG\/16\/1\/32092"],"award-info":[{"award-number":["RG\/16\/1\/32092"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["CH\/16\/2\/32089"],"award-info":[{"award-number":["CH\/16\/2\/32089"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiovascular Magnetic Resonance"],"published-print":{"date-parts":[[2024]]},"DOI":"10.1016\/j.jocmr.2024.101073","type":"journal-article","created":{"date-parts":[[2024,8,2]],"date-time":"2024-08-02T05:36:40Z","timestamp":1722577000000},"page":"101073","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Occult coronary microvascular dysfunction and ischemic heart disease in patients with diabetes and heart failure"],"prefix":"10.1016","volume":"26","author":[{"given":"Noor","family":"Sharrack","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Louise A.E.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan","family":"Farley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Wahab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas","family":"Jex","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharmaine","family":"Thirunavukarasu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amrit","family":"Chowdhary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miroslawa","family":"Gorecka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wasim","family":"Javed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Xue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eylem","family":"Levelt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erica","family":"Dall\u2019Armellina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Kellman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pankaj","family":"Garg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John P.","family":"Greenwood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sven","family":"Plein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter P.","family":"Swoboda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jocmr.2024.101073_bib1","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1093\/eurheartj\/ehz486","article-title":"2019 ESC guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD","volume":"41","author":"Cosentino","year":"2020","journal-title":"Eur Heart J"},{"issue":"2","key":"10.1016\/j.jocmr.2024.101073_bib2","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S2213-8587(14)70219-0","article-title":"Type 2 diabetes and incidence of cardiovascular diseases: a cohort study in 1.9 million people","volume":"3","author":"Shah","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"10","key":"10.1016\/j.jocmr.2024.101073_bib3","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1161\/01.CIR.100.10.1134","article-title":"Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association","volume":"100","author":"Grundy","year":"1999","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.jocmr.2024.101073_bib4","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1177\/1479164112471064","volume":"10","author":"Cubbon","year":"2013","journal-title":"Diabetes Vasc Dis Res"},{"issue":"2","key":"10.1016\/j.jocmr.2024.101073_bib5","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s00125-021-05592-3","article-title":"Prediabetes and risk of mortality, diabetes-related complications and comorbidities: umbrella review of meta-analyses of prospective studies","volume":"65","author":"Schlesinger","year":"2022","journal-title":"Diabetologia"},{"issue":"8","key":"10.1016\/j.jocmr.2024.101073_bib6","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.2337\/diacare.27.8.1879","article-title":"The incidence of congestive heart failure in type 2 diabetes: an update","volume":"27","author":"Nichols","year":"2004","journal-title":"Diabetes Care"},{"issue":"10","key":"10.1016\/j.jocmr.2024.101073_bib7","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1093\/eurheartj\/ehn156","article-title":"Diabetes, left ventricular systolic dysfunction, and chronic heart failure","volume":"29","author":"MacDonald","year":"2008","journal-title":"Eur Heart J"},{"issue":"9","key":"10.1016\/j.jocmr.2024.101073_bib8","doi-asserted-by":"crossref","first-page":"3316","DOI":"10.1210\/jc.2016-1318","article-title":"A novel and practical screening tool for the detection of silent myocardial infarction in patients with type 2 diabetes","volume":"101","author":"Swoboda","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"10.1016\/j.jocmr.2024.101073_bib9","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1161\/CIRCULATIONAHA.113.001180","article-title":"Prevalence, incidence, and implications of silent myocardial infarctions in patients with diabetes mellitus","volume":"127","author":"Scirica","year":"2013","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.jocmr.2024.101073_bib10","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1161\/CIRCULATIONAHA.107.727826","article-title":"Incidence and prognostic implication of unrecognized myocardial scar characterized by cardiac magnetic resonance in diabetic patients without clinical evidence of myocardial infarction","volume":"118","author":"Kwong","year":"2008","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.jocmr.2024.101073_bib11","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1148\/radiol.11110967","article-title":"Prognostic significance of unrecognized myocardial infarction detected with MR imaging in patients with impaired fasting glucose compared with those with diabetes","volume":"262","author":"Yoon","year":"2012","journal-title":"Radiology"},{"issue":"1","key":"10.1016\/j.jocmr.2024.101073_bib12","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1161\/01.CIR.0000078641.19365.4C","article-title":"Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance","volume":"108","author":"McCrohon","year":"2003","journal-title":"Circulation"},{"issue":"27","key":"10.1016\/j.jocmr.2024.101073_bib13","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1093\/eurheartj\/ehv134","article-title":"Clinical diabetic cardiomyopathy: a two-faced disease with restrictive and dilated phenotypes","volume":"36","author":"Seferovic","year":"2015","journal-title":"Eur Heart J"},{"issue":"6","key":"10.1016\/j.jocmr.2024.101073_bib14","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1177\/0300060516675504","article-title":"Coronary microvascular dysfunction in diabetes mellitus","volume":"45","author":"Kibel","year":"2017","journal-title":"J Int Med Res"},{"issue":"11","key":"10.1016\/j.jocmr.2024.101073_bib15","doi-asserted-by":"crossref","first-page":"377","DOI":"10.4330\/wjc.v2.i11.377","article-title":"Coronary microvascular dysfunction in diabetes mellitus: a review","volume":"2","author":"Picchi","year":"2010","journal-title":"World J Cardiol"},{"issue":"9","key":"10.1016\/j.jocmr.2024.101073_bib16","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1161\/CIRCULATIONAHA.107.763730","article-title":"Impaired tissue perfusion: a pathology common to hypertension, obesity, and diabetes mellitus","volume":"118","author":"Levy","year":"2008","journal-title":"Circulation"},{"issue":"36","key":"10.1016\/j.jocmr.2024.101073_bib17","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.jocmr.2024.101073_bib18","doi-asserted-by":"crossref","DOI":"10.1186\/s12968-020-00607-1","article-title":"Standardized cardiovascular magnetic resonance imaging (CMR) protocols: 2020 update","volume":"22","author":"Kramer","year":"2020","journal-title":"J Cardiovasc Magn Reson"},{"issue":"1","key":"10.1016\/j.jocmr.2024.101073_bib19","doi-asserted-by":"crossref","DOI":"10.1186\/s12968-017-0355-5","article-title":"Myocardial perfusion cardiovascular magnetic resonance: optimized dual sequence and reconstruction for quantification","volume":"19","author":"Kellman","year":"2017","journal-title":"J Cardiovasc Magn Reson"},{"issue":"1","key":"10.1016\/j.jocmr.2024.101073_bib20","doi-asserted-by":"crossref","DOI":"10.1186\/s12968-018-0462-y","article-title":"Fully automated, inline quantification of myocardial blood flow with cardiovascular magnetic resonance: repeatability of measurements in healthy subjects","volume":"20","author":"Brown","year":"2018","journal-title":"J Cardiovasc Magn Reson"},{"issue":"12","key":"10.1016\/j.jocmr.2024.101073_bib21","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1093\/ehjci\/jeu142","article-title":"The microvascular effects of insulin resistance and diabetes on cardiac structure, function, and perfusion: a cardiovascular magnetic resonance study","volume":"15","author":"Larghat","year":"2014","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"1","key":"10.1016\/j.jocmr.2024.101073_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4239\/wjd.v9.i1.1","article-title":"Cardiac autonomic neuropathy: risk factors, diagnosis and treatment","volume":"9","author":"Serhiyenko","year":"2018","journal-title":"World J Diabetes"},{"issue":"9","key":"10.1016\/j.jocmr.2024.101073_bib23","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1001\/2012.jama.11089","article-title":"Prevalence and prognosis of unrecognized myocardial infarction determined by cardiac magnetic resonance in older adults","volume":"308","author":"Schelbert","year":"2012","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.jocmr.2024.101073_bib24","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1016\/j.jcmg.2018.12.022","article-title":"Automated pixel-wise quantitative myocardial perfusion mapping by CMR to detect obstructive coronary artery disease and coronary microvascular dysfunction: validation against invasive coronary physiology","volume":"12","author":"Kotecha","year":"2019","journal-title":"JACC Cardiovasc Imaging"},{"issue":"15","key":"10.1016\/j.jocmr.2024.101073_bib25","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1161\/CIRCULATIONAHA.112.120402","article-title":"Association between coronary vascular dysfunction and cardiac mortality in patients with and without diabetes mellitus","volume":"126","author":"Murthy","year":"2012","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.jocmr.2024.101073_bib26","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.2337\/dc19-2172","article-title":"Reduced myocardial perfusion reserve in type 2 diabetes is caused by increased perfusion at rest and decreased maximal perfusion during stress","volume":"43","author":"Sorensen","year":"2020","journal-title":"Diabetes Care"},{"issue":"24","key":"10.1016\/j.jocmr.2024.101073_bib27","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1161\/CIRCULATIONAHA.116.022194","article-title":"Clinical update: cardiovascular disease in diabetes mellitus: atherosclerotic cardiovascular disease and heart failure in type 2 diabetes mellitus - mechanisms, management, and clinical considerations","volume":"133","author":"Low Wang","year":"2016","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.jocmr.2024.101073_bib28","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s10741-011-9257-z","article-title":"Diabetic cardiomyopathy: understanding the molecular and cellular basis to progress in diagnosis and treatment","volume":"17","author":"Falcao-Pires","year":"2012","journal-title":"Heart Fail Rev"},{"issue":"12","key":"10.1016\/j.jocmr.2024.101073_bib29","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.018998","article-title":"Microvascular disease and incident heart failure among individuals with type 2 diabetes mellitus","volume":"10","author":"Kaze","year":"2021","journal-title":"J Am Heart Assoc"},{"issue":"9","key":"10.1016\/j.jocmr.2024.101073_bib30","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1136\/hrt.2009.183624","article-title":"Diabetes: a driver for heart failure","volume":"97","author":"Voors","year":"2011","journal-title":"Heart"},{"issue":"1","key":"10.1016\/j.jocmr.2024.101073_bib31","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jchf.2017.08.020","article-title":"Association between type 2 diabetes and all-cause hospitalization and mortality in the UK general heart failure population:\u00a0stratification by diabetic glycemic control and medication intensification","volume":"6","author":"Lawson","year":"2018","journal-title":"JACC Heart Fail"},{"issue":"5","key":"10.1016\/j.jocmr.2024.101073_bib32","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.ahj.2011.07.030","article-title":"Intensive glycemic control has no impact on the risk of heart failure in type 2 diabetic patients: evidence from a 37,229 patient meta-analysis","volume":"162","author":"Castagno","year":"2011","journal-title":"Am Heart J"},{"issue":"22","key":"10.1016\/j.jocmr.2024.101073_bib33","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","article-title":"Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes","volume":"373","author":"Zinman","year":"2015","journal-title":"N Engl J Med"}],"container-title":["Journal of Cardiovascular Magnetic Resonance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1097664724011001?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1097664724011001?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T12:58:43Z","timestamp":1778590723000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1097664724011001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024]]}},"alternative-id":["S1097664724011001"],"URL":"https:\/\/doi.org\/10.1016\/j.jocmr.2024.101073","relation":{},"ISSN":["1097-6647"],"issn-type":[{"value":"1097-6647","type":"print"}],"subject":[],"published":{"date-parts":[[2024]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Occult coronary microvascular dysfunction and ischemic heart disease in patients with diabetes and heart failure","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiovascular Magnetic Resonance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jocmr.2024.101073","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc. on behalf of Society for Cardiovascular Magnetic Resonance.","name":"copyright","label":"Copyright"}],"article-number":"101073"}}